| Old Articles: <Older 40451-40460 Newer> |
|---|
 |
The Motley Fool
February 26, 2010
Brian Orelli |
A Risky Deal, but at Least It's Cheap Glaxo licenses a preclinical compound from Regulus.   |
The Motley Fool
February 26, 2010
Rich Smith |
A Big Ol' Buy for Boeing United's check is in the mail, and that's good news for Boeing shareholders. Just don't be too shocked when, upon opening the envelope, you discover it's not as big a check as Boeing makes it out to be. |
The Motley Fool
February 26, 2010
Matthew Argersinger |
Patience Pays With These Stocks: 408% Why you should love stocks that are going nowhere fast. |
The Motley Fool
February 26, 2010
Brian Orelli |
Boning Up on Pfizer's Drug Fablyn looks OK on paper, but that isn't going to cut it in the crowded osteoporosis market. |
The Motley Fool
February 26, 2010
Brian Orelli |
Political Theater: More Entertaining Than Helpful Health-care reform, like health-care stocks, remains still stuck in limbo. |
The Motley Fool
February 26, 2010
Matt Koppenheffer |
Steve Jobs Puts His Foot Down on Dividends Jobs quashed an Apple dividend once again. Anyone have rotten tomatoes handy? |
The Motley Fool
February 26, 2010
Tim Beyers |
Has iTunes Peaked? Downloads take a dive in 2009. |
The Motley Fool
February 26, 2010
Rick Aristotle Munarriz |
No One Is Delisting Sirius XM Sirius XM doesn't want to go in reverse. It may not need to. |
The Motley Fool
February 26, 2010
Tim Beyers |
Why Developers Love the iPhone And why this Fool is still short Palm and Research In Motion. Not all smartphone users are created equal. Those who use iPhones are more apt to buy apps, a new report from AdMob says. |
The Motley Fool
February 26, 2010
Rick Aristotle Munarriz |
7 Reasons to Worry About Next Week Let's go over a few of the blue chips and seemingly recession-proof companies where analysts see the arrows pointing down on the bottom line next week. Some of the names may surprise you. |
| <Older 40451-40460 Newer> Return to current articles. |
